Metraipolis › archive › dc_2b818fc2cf0d

Tranylcypromine: a promising repurposed drug against Leishmaniases — Europe PMC PMID:41602770

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41602770
DOI
10.3389/fmicb.2025.1756231
License (as archived)
solo-consultazione
Archived
2026-11-06T21:47:42.401Z
SHA-256 of the archived text
4fe742888313ca86ad96403583fc4bb1110db673a515be7973a6b542e3b4f0c4
Stable URL of this page
https://metraipolis.com/documento/dc_2b818fc2cf0d

How to cite

Tranylcypromine: a promising repurposed drug against Leishmaniases — Europe PMC PMID:41602770 — Europe PMC (en), https://europepmc.org/article/MED/41602770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b818fc2cf0d (Metraipolis archive dc_2b818fc2cf0d, sha256 4fe742888313ca86ad96403583fc4bb1110db673a515be7973a6b542e3b4f0c4)
BibTeX
@misc{dc2b818fc2cf0d,
  title = {Tranylcypromine: a promising repurposed drug against Leishmaniases — Europe PMC PMID:41602770},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41602770},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b818fc2cf0d; sha256 4fe742888313ca86ad96403583fc4bb1110db673a515be7973a6b542e3b4f0c4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41602770. Agents can read the archived copy with the MCP tool read_document.